NervGen Pharma (NGENF) Q2 2025 Earnings

15MayConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-0.08
-0.06
-0.05
-0.03

Details

Expected EPS
-0.0590614
Actual EPS
-0.0416904
Surprise EPS
0.02
Surprise Percent
+29.41%

Description

NervGen Pharma (NGENF) has reported earnings of -0.0416904 per share for Q2 2025.

0 Comments

Share your thoughts